Zilver PTX Drug-Eluting Peripheral Stent
Cook Ireland, Ltd. · Decision date Nov 6, 2026
What did the FDA decide?
FDA record P100022/S046 is a 30-Day Notice supplement tied to PMA P100022, so it concerns a manufacturing process change rather than a fresh approval of the stent system. The stated change was approval of new equipment used for manufacturing packaging for the Zilver PTX Drug-Eluting Peripheral Stent and Zilver Vascular Stent.
The source does not describe the equipment itself, the packaging step affected, or any clinical or labeling change. It also does not provide evidence of safety or effectiveness; it only records the packaging-related manufacturing change for this PMA supplement.
FDA approval order statement
approval of new equipment used for manufacturing packaging for the Zilver PTX Drug-Eluting Peripheral Stent and Zilver Vascular Stent
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Nov 6, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P100022/S046
- Regulatory pathway
- PMA supplement
- Applicant
- Cook Ireland, Ltd.
- Product code
- NIU
- Decision code
- OK30
- Decision date
- Nov 6, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stent, superficial femoral artery, drug-eluting.
- Applicant
- Cook Ireland, Ltd.
- Product code
- NIU
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P100022. Subsequent supplements may change the device or its indications.
FDA decision timeline
P100022 · Original PMA
ZILVER PTX DRUG-ELUTING PERIPHERAL STENT
P100022/S046 received
Application receipt date recorded by FDA.
P100022/S046 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P100022. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P100022
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Cook Ireland, Ltd. | PMA approval | Nov 14, 2012 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Cook Ireland, Ltd.
- Headquarters
- Not reported
- Brand website
- cookmedical.com
- FDA applicant address
- O' Halloran Rd., National Technology Park, Limerick
Sources and methodology
- Original FDA record: P100022/S046
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records